ICON plc | Clinical Research Organisation (CRO) for Drug Development

Leveraging historical data for use in rare disease trials

Understanding the Bayesian and Frequentist approaches.

ICER’s impact on payer decision making

Results of ICON’s third annual survey.

Mitigating the impact of COVID-19 on cardiovascular trials

Ensure patient safety and trial integrity during a global pandemic.

Dynamics of patient centricity in clinical research

Exploring the patient dynamic from different perspectives.

Webinars

Interactive and web-based health economic models

7 December 2020. Register now.

HTA and market access implications for gene therapies

8 December 2020. Register now.

Biomarker assays - bioanalytical meets CLIA

9 December, 2020. Register now.

Helping NASH study sites to succeed

10 December. Register now.

Webinar: The application of artificial intelligence and machine learning to imaging systems and data platforms

Imaging AI and machine learning – Beyond the hype

16 December, 2020. Register now.

The IVDR journey: A roadmap to meet 2022 deadlines

17 December 2020. Register now.

Financial Times Digital Dialogues: Resilient clinical trials

FT Digital Dialogues: Resilient clinical trials

3 February, 2021. Regsiter today.

Featured Services

COVID-19 clinical operations

Keeping your clinical trial on track in an evolving environment.

Site & Patient Solutions

Transforming recruitment through patient-centric trials and real-world, real-time data.

Biotech

ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.

Functional Resourcing

From recruitment of a single clinical professional to managing entire global functions.

Biosimilars

ICON can support product design, development and registration, regulatory support and commercialisation of Biosimilars.

Increasing Site and Patient Compliance

FIRECREST: Digital solutions to increase efficiency in clinical trials by driving site performance.

ICON Insights

03 December 2020

Bringing an invisible battle to the forefront: How to better design military-related TBI clinical trials

A form of acquired brain injury that occurs when trauma causes damage to the brain, TBI has become increasingly apparent in military personnel.

19 November 2020

C diff and COVID-19, is this a health risk that can be dealt with sooner than later?

Today, with the development, widespread use, and poor prescribing practices of antibiotics over time, C diff infection rates have increased exponentially.

18 November 2020

Agile clinical monitoring: the flexibility to adapt to study dynamics

The use of a well-executed hybrid monitoring strategy is the way forward for companies to remain agile adapting to therapeutic, regional and patient considerations.

12 November 2020

Dirty data: How to manage data from wearables in clinical trials

How to manage data from wearables in clinical trials — from overcoming regulatory issues to handling challenges associated with dirty data.

12 October 2020

Mapping digital health transformation: From digital endpoints to device selection

At ICON, our framework maps the transition from device selection to digital endpoint validation, leading to a better data management and risk mitigation.

08 October 2020

Safety reporting in LATAM is changing, are you ready?

LATAM is evolving to electronic safety reporting and it is essential to be prepared for it.

02 October 2020

Digital health technologies: Implementing innovation in cardiovascular studies during COVID-19

The COVID-19 pandemic has led to the implementation of more efficient trial designs and operational execution, especially with regard to cardiovascular (CV) studies.

29 September 2020

Wearables across phases: How to best incorporate digital endpoints at every stage of clinical research

Once implemented properly, digital endpoints have the potential to enhance any trial, whether observational or interventional, or early or late phase.

22 September 2020

New UKCA (UK Conformity Assessed) marking

As the UK’s transition period to leave the European Union (EU) rapidly comes to an end, the Medicines and Healthcare products Regulatory Agency (MHRA) recently published new guidance on how it will regulate medical devices starting in January 2021.

Coronavirus Observatory

Aggregated news, stats and social media on covid-19 clinical trials. Visit Observatory

Services

Sectors

Therapeutics

Innovation

Insights

News & Events

About ICON

The evolution of HIV treatments

The IVDR journey

Agile Clinical Monitoring

Challenges and opportunities in traumatic brain injury clinical trials